CGON - CG Oncology, Inc. Common stock
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$82.57
DETAILS
HIGH:
$93.00
LOW:
$70.00
MEDIAN:
$82.00
CONSENSUS:
$82.57
UPSIDE:
28.51%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | -15.0% |
| EBIT Margin | -3985.0% |
| EBITDA Margin | -3949.3% |
| Operating Margin | -4722.1% |
| Pretax Margin | -3985.0% |
| Cont. Ops Margin | -3985.0% |
| Net Margin | -3985.0% |
| Bottom Line Margin | -3985.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 24.63 |
| Quick Ratio | 24.58 |
| Solvency Ratio | -4.092 |
| Cash Ratio | 1.05 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-19.94
Peers avg: 18.0
|
| PEG Ratio | -0.42 |
| Forward PEG | -0.42 |
| Price/Book | 4.26 |
| Price/Sales | 794.47 |
| Price/FCF | -24.23 |
| Price/Op Cash Flow | -24.25 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0089 |
| Debt/Equity | 0.0093 |
| Debt/Capital | 0.0092 |
| Long-Term Debt/Capital | 0.0080 |
| Financial Leverage | 1.05 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.01 |
| Operating Cash Flow Ratio | -4.292 |
| Operating Cash Flow/Sales | -3275.9% |
| Free Cash Flow/Operating Cash Flow | 100.1% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -174.37 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -144.64 |
| Operating Cash Flow Coverage | -18.85 |
| Capital Expenditure Coverage | -987.66 |
| Dividend + Capital Expenditure Coverage | -987.66 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.05 |
| EPS | -2.083 |
| Debt/Share | 0.0908 |
| Cash/Share | 9.60 |
| Book Value/Share | 9.74 |
| Tangible BV/Share | 9.60 |
| Equity/Share | 9.74 |
| Operating Cash Flow/Share | -1.712 |
| Capital Expenditure/Share | 0.002 |
| FCF/Share | -1.714 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.844 |
| Price/Fair Value | 4.26 |
| Debt/Market Cap | 0.0022 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -19.96 |